Edesa Biotech Research, Inc.

3 records totalling $37,134,812.00 CAD, from official Government of Canada open data.

Embed this chart

Lobbying registry — possible match matched by name

An organization with this name appears in 40 federal lobbying registrations (3 currently active), between 2020 and 2026.

947006-367429-17 775866-370236-7 — Earnscliffe Strategy Group 962675-383530-2 — Earnscliffe Strategies

Matched automatically by organization name; a different organization with the same name is possible. The Registry of Lobbyists is the authoritative source. Lobbying is legal and regulated — this is context, not an allegation.

By department

Innovation, Science and Economic Development Canada $37,053,500 2 records
National Research Council Canada $81,312 1 record

Records

Edesa Biotech Research, Inc. $23,000,000.00
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
SIF Stream 1- R&D
FY 2023-2024
Canada

The project will focus on the activities required for Phase 3 clinical trials/regulatory approval for their novel antibody treatment (EB05) targeting acute respiratory distress syndrome (ARDS), the mo...

Edesa Biotech Research, Inc. $14,053,500.00
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
SIF Stream 1 - R&D
FY 2020-2021
Canada

Edesa will complete a pre-clinical study, and Phase II trials to evaluate the safety and efficacy of an antibody treatment (EB05) in hospitalized COVID-19 patients.

Edesa Biotech Research, Inc. $81,312.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
FY 2020-2021
Canada

The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.